Overview
Choledochal cyst (also known as bile duct cyst or choledochal malformation) is a congenital condition characterized by cystic dilatation of the bile ducts, which are the tubes that carry bile from the liver and gallbladder to the small intestine. These cysts can occur at various points along the biliary tree and are classified into five types (Todani classification), with Type I (fusiform dilatation of the common bile duct) being the most common. The condition primarily affects the hepatobiliary system but can have secondary effects on the pancreas and gastrointestinal tract. The classic triad of symptoms includes abdominal pain (typically in the right upper quadrant), jaundice (yellowing of the skin and eyes), and a palpable abdominal mass, though this complete triad is present in only a minority of patients. In infants, the condition may present with obstructive jaundice and acholic (pale) stools, while older children and adults more commonly experience recurrent abdominal pain, cholangitis (infection of the bile ducts), or pancreatitis. If left untreated, choledochal cysts carry a significant risk of complications including biliary cirrhosis, portal hypertension, cholangiocarcinoma (bile duct cancer), and recurrent cholangitis. The standard treatment for choledochal cysts is surgical excision of the cyst with reconstruction of the biliary tract, most commonly through a Roux-en-Y hepaticojejunostomy (connecting the remaining bile duct directly to a loop of small intestine). Complete cyst excision is strongly recommended over simple drainage procedures because of the well-documented risk of malignant transformation in retained cyst tissue, which increases with age. The condition is more prevalent in females and in East Asian populations, particularly in Japan where incidence rates are notably higher. Early diagnosis and surgical intervention generally lead to excellent long-term outcomes.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
6 eventsBeijing Tsinghua Chang Gung Hospital
Beijing Tsinghua Chang Gung Hospital
Beijing Tsinghua Chang Gung Hospital
Zhujiang Hospital
Guangzhou Women and Children's Medical Center — NA
María Teresa Moreno Asencio
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Choledochal cyst.
4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Choledochal cyst.
Community
No community posts yet. Be the first to share your experience with Choledochal cyst.
Start the conversation →Latest news about Choledochal cyst
No recent news articles for Choledochal cyst.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Choledochal cyst
What is Choledochal cyst?
Choledochal cyst (also known as bile duct cyst or choledochal malformation) is a congenital condition characterized by cystic dilatation of the bile ducts, which are the tubes that carry bile from the liver and gallbladder to the small intestine. These cysts can occur at various points along the biliary tree and are classified into five types (Todani classification), with Type I (fusiform dilatation of the common bile duct) being the most common. The condition primarily affects the hepatobiliary system but can have secondary effects on the pancreas and gastrointestinal tract. The classic tria
How is Choledochal cyst inherited?
Choledochal cyst follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Are there clinical trials for Choledochal cyst?
Yes — 4 recruiting clinical trials are currently listed for Choledochal cyst on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Choledochal cyst?
6 specialists and care centers treating Choledochal cyst are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.